Sowell Financial Services LLC Sells 31,695 Shares of Baxter International Inc. $BAX

Sowell Financial Services LLC lessened its position in Baxter International Inc. (NYSE:BAX) by 71.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,703 shares of the medical instruments supplier’s stock after selling 31,695 shares during the quarter. Sowell Financial Services LLC’s holdings in Baxter International were worth $305,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CX Institutional lifted its position in Baxter International by 2.3% during the 3rd quarter. CX Institutional now owns 19,858 shares of the medical instruments supplier’s stock worth $477,000 after acquiring an additional 448 shares during the last quarter. Baird Financial Group Inc. grew its position in shares of Baxter International by 1.1% in the second quarter. Baird Financial Group Inc. now owns 44,722 shares of the medical instruments supplier’s stock valued at $953,000 after purchasing an additional 476 shares during the last quarter. CWA Asset Management Group LLC grew its position in shares of Baxter International by 5.0% in the third quarter. CWA Asset Management Group LLC now owns 12,617 shares of the medical instruments supplier’s stock valued at $303,000 after purchasing an additional 599 shares during the last quarter. Empirical Finance LLC increased its stake in shares of Baxter International by 3.5% in the second quarter. Empirical Finance LLC now owns 18,170 shares of the medical instruments supplier’s stock worth $387,000 after purchasing an additional 608 shares during the period. Finally, CYBER HORNET ETFs LLC increased its stake in shares of Baxter International by 52.4% in the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 740 shares during the period. Institutional investors and hedge funds own 90.19% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on BAX. UBS Group boosted their price objective on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Wall Street Zen lowered Baxter International from a “buy” rating to a “hold” rating in a report on Saturday, October 10th. Wells Fargo & Company lifted their price target on Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Barclays began coverage on Baxter International in a report on Wednesday, October 7th. They set an “underweight” rating and a $20.00 price target for the company. Finally, Citigroup cut their price target on Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a report on Monday, October 5th. One investment analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $21.73.

Baxter International Stock Down 0.0%

Shares of BAX opened at $25.30 on Tuesday. The company has a 50-day simple moving average of $24.77 and a 200-day simple moving average of $21.27. The firm has a market capitalization of $13.08 billion, a P/E ratio of -12.22, a P/E/G ratio of 3.83 and a beta of 0.65. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. Baxter International Inc. has a 52 week low of $15.73 and a 52 week high of $30.00.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.19. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business had revenue of $2.96 billion during the quarter, compared to analysts’ expectations of $2.80 billion. During the same quarter last year, the company earned $0.59 earnings per share. The firm’s revenue was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. On average, equities research analysts expect that Baxter International Inc. will post 2.04 earnings per share for the current year.

Baxter International Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 1st. Shareholders of record on Friday, August 28th were given a $0.01 dividend. The ex-dividend date was Friday, August 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Baxter International’s dividend payout ratio (DPR) is currently -1.93%.

Baxter International Profile

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.